Introduction to 8 27 2015 Session 3 Discussion
Let's dive into the details surrounding 8 27 2015 Session 3 Discussion. Panelist field questions from the audience.
8 27 2015 Session 3 Discussion Comprehensive Overview
Nathan Wolfe, CEO, Metabiota. Gordon Woo, Catastrophist, Risk Management Solutions. Panelist field questions from the audience.
Panelists field questions from the audience.
Summary & Highlights for 8 27 2015 Session 3 Discussion
- Panelists field questions from the audience.
- Paolo Sison, Director Innovative Finance, Gavi, The Vaccine Alliance.
- Session 3 Discussion
- Adam Bornstein, Specialist Innovative Health Financing, The Global Fund.
- Christopher Egerton-Warburton, Partner, Lion's Head Global Partners.
That wraps up our extensive overview of 8 27 2015 Session 3 Discussion.